XTL Biopharmaceuticals Ltd (XTLB)
2.693
+0.04
(+1.62%)
USD |
NASDAQ |
May 17, 16:00
2.71
+0.02
(+0.63%)
After-Hours: 20:00
XTL Biopharmaceuticals Cash and Short Term Investments (Quarterly): 2.339M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.339M |
December 31, 2023 | 2.006M |
September 30, 2023 | 2.206M |
June 30, 2023 | 2.383M |
March 31, 2023 | 2.876M |
December 31, 2022 | 3.721M |
September 30, 2022 | 4.387M |
June 30, 2022 | 5.156M |
March 31, 2022 | 2.792M |
December 31, 2021 | 6.127M |
September 30, 2021 | 3.011M |
June 30, 2021 | 6.297M |
March 31, 2021 | 3.394M |
December 31, 2020 | 6.042M |
September 30, 2020 | 3.752M |
June 30, 2020 | 4.027M |
March 31, 2020 | 4.257M |
December 31, 2019 | 6.728M |
September 30, 2019 | 4.642M |
June 30, 2019 | 4.76M |
March 31, 2019 | 5.062M |
December 31, 2018 | 8.122M |
September 30, 2018 | 5.414M |
June 30, 2018 | 5.458M |
March 31, 2018 | 5.541M |
Date | Value |
---|---|
December 31, 2017 | 6.094M |
September 30, 2017 | 6.085M |
June 30, 2017 | 6.325M |
March 31, 2017 | 6.755M |
December 31, 2016 | 2.433M |
September 30, 2016 | 2.322M |
June 30, 2016 | 2.967M |
March 31, 2016 | 3.109M |
December 31, 2015 | 4.068M |
September 30, 2015 | 4.556M |
June 30, 2015 | 5.101M |
March 31, 2015 | 1.753M |
December 31, 2014 | 2.159M |
September 30, 2014 | 2.905M |
June 30, 2014 | 3.26M |
March 31, 2014 | 3.871M |
December 31, 2013 | 4.165M |
September 30, 2013 | 4.144M |
June 30, 2013 | 2.053M |
March 31, 2013 | 2.72M |
December 31, 2012 | 3.312M |
September 30, 2012 | 2.943M |
June 30, 2012 | 3.423M |
March 31, 2012 | 3.934M |
December 31, 2011 | 1.495M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.006M
Minimum
Dec 2023
6.728M
Maximum
Dec 2019
4.045M
Average
3.890M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Compugen Ltd | 50.68M |
Pluri Inc | 26.01M |
BioLine Rx Ltd | 42.99M |
Can Fite Biofarma Ltd | 8.922M |
BiomX Inc | 14.91M |